Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $78.27 +3.46%
EPS Growth %: +27.1%
Financial Fact:
Cash dividend declared per common share: 0.1
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +27.1%
Financial Fact:
Cash dividend declared per common share: 0.1
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q2 EPS of $1.02, $0.09 better than the analyst estimate of $0.93. Revenue for the quarter came in at $500.1 million versus the consensus estimate of $470.53 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Nomura/Instinet Upgrades MR DIY Group M Bhd (MRDIY:MK) to Buy
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
